Altshuler Shaham’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-16
Closed -$3.85K 478
2025
Q4
$3.85K Hold
16
﹤0.01% 344
2025
Q3
$4.38K Sell
16
-1
-6% -$273 ﹤0.01% 269
2025
Q2
$4.39K Hold
17
﹤0.01% 239
2025
Q1
$3.81K Buy
+17
New +$3.97K ﹤0.01% 250
2023
Q1
Sell
-120
Closed -$25K 452
2022
Q4
$25K Sell
120
-140
-54% -$30.8K ﹤0.01% 342
2022
Q3
$57K Buy
+260
New +$59.2K ﹤0.01% 203
2022
Q2
Sell
-155
Closed -$38K 548
2022
Q1
$38K Sell
155
-937
-86% -$227K ﹤0.01% 436
2021
Q4
$287K Buy
1,092
+29
+3% +$7.53K ﹤0.01% 228
2021
Q3
$281K Buy
1,063
+438
+70% +$120K ﹤0.01% 226
2021
Q2
$154K Hold
625
﹤0.01% 281
2021
Q1
$121K Sell
625
-174
-22% -$34.9K ﹤0.01% 203
2020
Q4
$168K Buy
799
+26
+3% +$5.18K ﹤0.01% 175
2020
Q3
$132K Buy
773
+29
+4% +$5.36K ﹤0.01% 151
2020
Q2
$143K Sell
744
-107
-13% -$17.5K ﹤0.01% 142
2020
Q1
$126K Sell
851
-864
-50% -$138K 0.01% 155
2019
Q4
$265K Buy
1,715
+5
+0.3% +$721 0.01% 125
2019
Q3
$231K Buy
1,710
+171
+11% +$22.4K 0.01% 115
2019
Q2
$642K Buy
1,539
+89
+6% +$9.86K 0.03% 97
2019
Q1
$42K Buy
1,450
+427
+42% +$44.1K ﹤0.01% 162
2018
Q4
$37K Buy
1,023
+273
+36% +$29.3K ﹤0.01% 131
2018
Q3
$24K Hold
750
﹤0.01% 168
2018
Q2
$21K Hold
750
﹤0.01% 137
2018
Q1
$21K Hold
750
﹤0.01% 131
2017
Q4
$19K Buy
+750
New +$62K ﹤0.01% 126

Other funds holding RMD

Altshuler Shaham's RMD Position: Q1 2026 in Review

Altshuler Shaham sold out of ResMed (RMD) in Q1 2026, closing a stake of 16 shares — an estimated $3.85K sold.

Altshuler Shaham first reported a position in RMD in Q4 2017 and held it in 24 quarters. The position peaked at $642K in Q2 2019. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Altshuler Shaham reported no remaining ResMed position as of Q1 2026 after selling out during the quarter.
  • Altshuler Shaham sold 16 ResMed shares in Q1 2026, an estimated $3.85K.
  • Altshuler Shaham first reported a position in ResMed in Q4 2017 and held it in 24 quarters.
  • Altshuler Shaham's ResMed position peaked at $642K in Q2 2019.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Altshuler Shaham's 13F filing for Q1 2026, filed 18 May 2026.